Diseases, Conditions, Syndromes

Exploring new research to combat disease-causing viruses

According to the US Center for Disease Control, the number of worldwide cases of poliomyelitis has decreased from 350,000 in 1988 to 407 in 2013. While the decline has been steady, polio has still not been eradicated. To ...

HIV & AIDS

HIV survives in our chromosomal DNA

It has been said that HIV cannot be cured since the virus propagates in places beyond the reach of antiviral agents. New research from Karolinska Institutet suggests, however, that this view is incorrect.

Diseases, Conditions, Syndromes

Targeting norovirus 'noxiousness'

Human noroviruses are the leading cause of viral gastroenteritis. Worldwide, about 200,000 children under age 5 die from norovirus infections every year. As of yet, no vaccines or antiviral agents have been licensed to treat ...

Diseases, Conditions, Syndromes

Predicting the outcome of hepatitis C virus treatment

Millions of people throughout the world are infected with hepatitis C virus (HCV), which can lead to cirrhosis of the liver and cancer. Directly acting antiviral agents inhibit viral proteins and have been used to successfully ...

Diseases, Conditions, Syndromes

Better long-term outcomes with low hep C viral load

(HealthDay)—In patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), low HCV viral load predicts better long-term surgical outcomes, regardless of the serologic eradication of HCV, according to research ...

Medical research

Bird flu virus research awaits approval

A bird flu virus at the center of an international debate sits in a padlocked freezer, deep inside a University of Wisconsin-Madison lab, waiting for new government guidelines that will allow researchers to continue unlocking ...

Diseases, Conditions, Syndromes

Combination of oral drugs suppresses common type of hepatitis C

A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.

page 1 from 2